Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen

AIMS: The antiviral agent favipiravir is likely to be co-prescribed with acetaminophen (paracetamol). The present study evaluated the possiblility of a pharmacokinetic interaction between favipiravir and acetaminophen, in vitro and in vivo. METHODS: The effect of favipivir on the transformation of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yanli, Harmatz, Jerold S, Epstein, Carol R, Nakagawa, Yukako, Kurosaki, Chie, Nakamura, Tetsuro, Kadota, Takumi, Giesing, Dennis, Court, Michael H, Greenblatt, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Drug Interactions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631180/
https://www.ncbi.nlm.nih.gov/pubmed/25808818
http://dx.doi.org/10.1111/bcp.12644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631180/
https://www.ncbi.nlm.nih.gov/pubmed/25808818
http://dx.doi.org/10.1111/bcp.12644

Ejemplares similares